Pancreatic cancer is likely to become the second most frequent cause of cancer-associated
mortality within the next decade. Surgical resection with adjuvant systemic chemotherapy …

Objective: The aim of this study was to develop and externally validate the first evidence-
based guidelines on minimally invasive pancreas resection (MIPR) before and during the …

Background The benefit and safety of laparoscopic pancreatoduodenectomy (LPD) for the
treatment of pancreatic or periampullary tumours remain controversial. Studies have shown …

Background Laparoscopic pancreatoduodenectomy may improve postoperative recovery
compared with open pancreatoduodenectomy. However, there are concerns that the …

Objective: The aim of the study was to analyze the outcomes of patients who have
undergone laparoscopic pancreaticoduodenectomy (LPD) in China. Summary Background …

Objective: To compare short-term and oncologic outcomes of patients with cancer who
underwent open pancreaticoduodenectomy (OPD) versus minimally invasive …

Remarkable progress has been made in treating pancreatic cancer over the past century,
including refinement of our surgical techniques and improvements in adjuvant and …

Objective: The aim of the study was to assess feasibility and outcomes of a multicenter
training program in laparoscopic pancreatoduodenectomy (LPD). Background: Whereas …

Background Safety of pancreaticoduodenectomy has improved significantly in the past 3
decades. Current inpatient and 30-d mortality rates are low. However, incidence and causes …

Background Clinically relevant postoperative pancreatic fistula (CR-POPF) after
pancreatoduodenectomy (PD) is a major complication that adversely affects recovery. The …